Latka logo
Isomorphic Labs logo

Isomorphic Labsrevenue & acquisition

Biotech & Drug DevelopersLondon, United KingdomFounded 2021

Isomorphic Labs was acquired.

Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach.

isomorphiclabs.comLinkedInUpdated Oct 30, 2026
Annual revenue
$45.7M
Sep 2024EST
Owner
Undisclosed
Date not on record

Isomorphic Labs revenue

Isomorphic Labs has not published its revenue. Growjo puts it at about $45.7M a year (September 2024).

$0
$20M
$40M
$0
–
$45.7M
20212022–232024
ReportedEstimateFounded 2021 at $0; every reading has its own bar
As ofRevenueSource
Sep 2024$45.7MESTGrowjo estimate

Who owns Isomorphic Labs

Another company owns Isomorphic Labs. The date and price of the deal are not on record.

Isomorphic Labs CEO

Eamon Jubbawy was CEO of Isomorphic Labs.

How this page is sourced

1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Oct 30, 2026Data disclaimerReport a correctionClaim this profileRun Isomorphic Labs? Join the podcast